Cytosorbents Newsroom

Balanced Hold Rating Amid Revenue Miss and Strategic Initiatives at CytoSorbents

TipRanksNov 11 06:31 ET

H.C. Wainwright Maintains Cytosorbents(CTSO.US) With Hold Rating, Maintains Target Price $1

Moomoo NewsNov 11 06:31 ET

Cytosorbents Is Maintained at Buy by EF Hutton

Dow JonesNov 8 18:14 ET

Cytosorbents Price Target Maintained With a $10.00/Share by EF Hutton

Dow JonesNov 8 18:14 ET

CytoSorbents Analyst Ratings

BenzingaNov 8 18:04 ET

CytoSorbents Analyst Ratings

BenzingaNov 4 12:25 ET

B.Riley Financial Maintains Cytosorbents(CTSO.US) With Buy Rating, Cuts Target Price to $3

Moomoo NewsOct 2 14:31 ET

CytoSorbents Analyst Ratings

BenzingaOct 1 15:50 ET

CytoSorbents Analyst Ratings

BenzingaAug 14 08:01 ET

H.C. Wainwright Maintains Cytosorbents(CTSO.US) With Hold Rating, Maintains Target Price $1

Moomoo NewsAug 14 06:31 ET

EF Hutton Maintains Cytosorbents(CTSO.US) With Buy Rating, Raises Target Price to $10

Moomoo NewsJul 30 09:50 ET

CytoSorbents Analyst Ratings

BenzingaJul 29 07:27 ET

CytoSorbents Analyst Ratings

BenzingaMay 15 10:07 ET

B. Riley Securities Reiterates Buy on CytoSorbents, Maintains $3 Price Target

BenzingaMay 15 10:06 ET

Hold Rating on Cytosorbents Amid Regulatory Uncertainties and Mixed Clinical Results

TipRanksMay 7 07:50 ET

CytoSorbents Analyst Ratings

BenzingaMay 7 06:57 ET

CytoSorbents Analyst Ratings

BenzingaMar 15 06:41 ET

Cytosorbents Financial and Clinical Study Outlook: Maintaining a Hold Rating

TipRanksMar 15 06:31 ET

CytoSorbents Holds Steady With Neutral Rating Amid Clinical and Financial Reassessments

TipRanksDec 29, 2023 10:56 ET

CytoSorbents Analyst Ratings

BenzingaDec 29, 2023 10:42 ET